Page last updated: 2024-12-08
2-butene-1,4-diol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
penitricin C: metabolite of penitricin; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 175854 |
| CHEMBL ID | 3188586 |
| MeSH ID | M0125589 |
Synonyms (52)
| Synonym |
|---|
| 2-butene-1,4-diol (trans) |
| unii-0p6354w2w1 |
| 0p6354w2w1 , |
| 2-butene-1,4-diol, (e)- |
| trans-2-butene-1,4-diol |
| 2-butene, 1,4-dihydroxy- |
| nsc 1260 |
| ai3-07551 |
| einecs 203-787-0 |
| agrisynth b2d |
| caswell no. 120 |
| epa pesticide chemical code 220100 |
| penitricin c |
| hsdb 5540 |
| 2-butene-1,4-diol, (2e)- |
| (2e)-but-2-ene-1,4-diol |
| 2-butene-1,4-diol |
| butenediol |
| 821-11-4 |
| trans-1,4-dihydroxy-2-butene |
| B3384 |
| (e)-but-2-ene-1,4-diol |
| AKOS000121146 |
| NCGC00249224-01 |
| dtxcid90809569 |
| tox21_202430 |
| cas-110-64-5 |
| NCGC00259979-01 |
| unii-2i323z5567 |
| 2i323z5567 , |
| ec 203-787-0 |
| 2-butene-1,4-diol, trans- |
| (e)-2-buten-1,4-diol |
| trans 2-butene-1,4-diol |
| trans-2-buten-1,4-diol |
| (2e)-2-butene-1,4-diol |
| Q-200249 |
| 2-butene-1,4-diol,c&t |
| (2e)-2-butene-1,4-diol # |
| (e)-2-butene-1,4-diol |
| CHEMBL3188586 |
| STL453720 |
| AS-58110 |
| A848856 |
| z/e-but-2-ene-1,4-dio |
| Q27237056 |
| rac-2-butene-1,4-diol |
| trans-but-2-ene-1,4-diol |
| CS-0130476 |
| EN300-27217 |
| DTXSID801033684 |
| Z237581088 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (6)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| acetylcholinesterase | Homo sapiens (human) | Potency | 35.4872 | 0.0025 | 41.7960 | 15,848.9004 | AID1347395 |
| AR protein | Homo sapiens (human) | Potency | 6.8380 | 0.0002 | 21.2231 | 8,912.5098 | AID1259243 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 17.1528 | 0.0006 | 57.9133 | 22,387.1992 | AID1259377; AID1259394 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 0.0173 | 0.0002 | 29.3054 | 16,493.5996 | AID743075 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 0.0017 | 0.1434 | 27.6121 | 59.8106 | AID1159516 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 19.4001 | 0.0006 | 27.2152 | 1,122.0200 | AID743202; AID743219 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 39.13
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (39.13) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||